Equities research analysts predict that Sensus Healthcare Inc (NASDAQ:SRTS) will post earnings per share of ($0.03) for the current fiscal quarter, according to Zacks Investment Research. Four analysts have provided estimates for Sensus Healthcare’s earnings, with the lowest EPS estimate coming in at ($0.04) and the highest estimate coming in at $0.00. Sensus Healthcare posted earnings of ($0.04) per share in the same quarter last year, which indicates a positive year over year growth rate of 25%. The business is expected to report its next quarterly earnings results on Thursday, August 1st.
On average, analysts expect that Sensus Healthcare will report full year earnings of ($0.13) per share for the current year, with EPS estimates ranging from ($0.25) to ($0.01). For the next year, analysts expect that the firm will report earnings of $0.25 per share, with EPS estimates ranging from $0.02 to $0.40. Zacks Investment Research’s earnings per share averages are a mean average based on a survey of research firms that follow Sensus Healthcare.
Sensus Healthcare (NASDAQ:SRTS) last announced its quarterly earnings results on Thursday, May 9th. The company reported ($0.13) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.02) by ($0.11). Sensus Healthcare had a negative net margin of 11.65% and a negative return on equity of 13.34%. The business had revenue of $5.44 million for the quarter, compared to analysts’ expectations of $7.81 million.
Shares of NASDAQ:SRTS traded up $0.04 during trading on Thursday, reaching $5.35. The company had a trading volume of 195 shares, compared to its average volume of 9,958. The company has a fifty day moving average price of $5.38. The stock has a market cap of $88.54 million, a PE ratio of -38.46 and a beta of -0.20. Sensus Healthcare has a 12 month low of $4.75 and a 12 month high of $9.23.
Large investors have recently bought and sold shares of the company. Garrison Bradford & Associates Inc. increased its stake in Sensus Healthcare by 275.1% during the 1st quarter. Garrison Bradford & Associates Inc. now owns 108,400 shares of the company’s stock valued at $761,000 after purchasing an additional 79,500 shares in the last quarter. B. Riley Wealth Management Inc. bought a new stake in Sensus Healthcare during the 1st quarter valued at about $117,000. Northern Trust Corp bought a new stake in Sensus Healthcare during the 4th quarter valued at about $86,000. Spark Investment Management LLC bought a new stake in Sensus Healthcare during the 1st quarter valued at about $155,000. Finally, B. Riley Financial Inc. bought a new stake in Sensus Healthcare during the 1st quarter valued at about $281,000. 9.56% of the stock is owned by hedge funds and other institutional investors.
About Sensus Healthcare
Sensus Healthcare, Inc manufactures and markets superficial radiation therapy devices to healthcare providers worldwide. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters.
Recommended Story: What is a Real Estate Investment Trust (REIT)?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Sensus Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sensus Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.